BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23539939)

  • 21. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Original report. Mucocele-like tumors of the breast: mammographic and sonographic appearances.
    Glazebrook K; Reynolds C
    AJR Am J Roentgenol; 2003 Apr; 180(4):949-54. PubMed ID: 12646434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy.
    Taşkin F; Köseoğlu K; Unsal A; Erkuş M; Ozbaş S; Karaman C
    Diagn Interv Radiol; 2011 Dec; 17(4):311-6. PubMed ID: 21328197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer underestimation rate of atypical ductal hyperplasia diagnosed by core-needle biopsy under imaging guidance.
    Wiratkapun C; Wibulpholprasert B; Lertsithichai P; Pulpinyo K; Wongwaisayawan S
    J Med Assoc Thai; 2005 Apr; 88(4):460-6. PubMed ID: 16146248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous biopsy in the definition of breast lesions: fine needle vs. 14-gauge].
    Nori J; Cariti G; Boeri C; Nori Bufalini F; Bianchi S; Vezzosi V; Di Lollo S
    Radiol Med; 1998 Jun; 95(6):630-4. PubMed ID: 9717547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interventional radiology in nonpalpable lesions of the breast].
    Tardivon A; Meunier M; El Khoury C; Thibault F
    J Radiol; 2003 Apr; 84(4 Pt 1):381-6. PubMed ID: 12759651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predictive of breast cancer in open biopsy in cases with atypical ductal hyperplasia diagnosed by ultrasound-guided core needle biopsy.
    Hong ZJ; Chu CH; Fan HL; Hsu HM; Chen CJ; Chan DC; Yu JC
    Eur J Surg Oncol; 2011 Sep; 37(9):758-64. PubMed ID: 21764539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
    Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
    AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term follow-up in 6 months is unnecessary for asymptomatic breast lesions with benign concordant results obtained at ultrasonography-guided 14-gauge core needle biopsy.
    Moon HJ; Jung I; Youk JH; Kim MJ; Kim EK
    Am J Surg; 2016 Jan; 211(1):152-8. PubMed ID: 26381659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy.
    Holley SO; Appleton CM; Farria DM; Reichert VC; Warrick J; Allred DC; Monsees BS
    Radiology; 2012 Nov; 265(2):379-84. PubMed ID: 22952379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal fibrosis of the breast: imaging characteristics and histopathologic correlation.
    Revelon G; Sherman ME; Gatewood OM; Brem RF
    Radiology; 2000 Jul; 216(1):255-9. PubMed ID: 10887257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
    Wiratkapun C; Lertsithichai P; Wibulpholprasert B
    J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is US-guided core needle biopsy (CNB) enough in probably benign nodules with interval growth?
    Yoon JH; Kim EK; Kwak JY; Moon HJ; Kim MJ
    Ultraschall Med; 2012 Dec; 33(7):E145-E150. PubMed ID: 23023453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical office-based ultrasound of the breast.
    Staren ED
    Am Surg; 1995 Jul; 61(7):619-26; discussion 627. PubMed ID: 7793744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?
    Kuo YL; Chang TW
    BMC Cancer; 2010 Jul; 10():371. PubMed ID: 20637074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of needle size and sonographic feature on accuracy of ultrasound-guided breast biopsy].
    Zhou J; Tang J; Luo Y; Wang Z; Lv F; Zhang M; Fu S; Xu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):41-5. PubMed ID: 24463114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An audit of the results of ultrasound-guided core needle biopsy of mammography versus ultrasound screen-detected breast lesions.
    Rhee SJ; Han BK; Ko ES; Choi JS; Ko EY
    J Clin Ultrasound; 2017 Jun; 45(5):261-266. PubMed ID: 28182285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.